Buda Juice, Inc (BUDA) Fair Value & Analysis
Consumer Defensive · US · Market cap $94.0M
Buda Juice, Inc
BUDA · US
Fair value as of: Jul 15, 2026
From 24 valuation models · updated 27 days ago
Share price −23.6% over the past month.
A strong business, but screening 50% overvalued on our models.
What matters now
- A high-quality business (quality 84/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case ($6.68). The favourable scenario is already priced in.
- The model range is unusually wide ($2.50 to $6.68). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (7 months)
White line = price, green steps = our fair value per fiscal year. As of Jul 15, 2026.
How to read this chart
7‑month range $7.16 – $10.86 · fair‑value band $2.50 – $6.68 · the $8.10 price screens above the $4.03 fair value. As of Jul 15, 2026.
Analysis
Buda Juice, Inc (BUDA) currently trades at $8.10, while our model-based Fair Value estimate is $4.03, implying the stock looks roughly 50.3% overvalued today. The Quality Score stands at 84/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Buda Juice, Inc generated revenue of $13.1M at a net margin of 23.7%. Revenue grew 17.7% year over year. It earns a return on equity of 25.8%. The balance sheet holds a net cash position of $1.1M. Fundamentals as of Jul 15, 2026
Our scenario range runs from $2.50 (bear case) to $6.68 (bull case); at $8.10, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at -50%, BUDA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings ($5.77) versus Asset-Based ($0.2000). Highest evidence: Residual Income (76).
Notify me when BUDA reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 82 · Market factors (momentum, volatility) 21
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2025 · reported fiscal years
Buda Juice, Inc reported revenue of $12.6M in FY2025 versus $9.4M in FY2023, a compound +15.9%/yr. Reported net income was $3.5M in FY2025, compounding +25.0%/yr from FY2023.
BUDA screens 50% overvalued. Compare with The Coca-Cola Company →
Peer Group
Beverages - Non-Alcoholic · 92 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Beverages - Non-Alcoholic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company KO | $87.05 | $36.57 | -58% |
| PepsiCo, Inc PEP | $139.02 | $106.91 | -23% |
| Monster Beverage Corporation MNST | $97.50 | $35.82 | -63% |
| Nongfu Spring Co 9633 | HK$41.44 | HK$30.72 | -26% |
| Coca-Cola Europacific Partners PLC CCEP | €92.10 | €85.41 | -7% |
| Keurig Dr Pepper Inc KDP | $31.25 | $30.99 | -1% |
| Coca-Cola FEMSA, S.A. KOF | $102.04 | $106.45 | +4% |
| Coca-Cola HBC AG EEE | €57.90 | €52.82 | -9% |
| Varun Beverages Limited VBL | ₹495.70 | ₹187.49 | -62% |
| Eastroc Beverage (Group) Co 605499 | ¥124.43 | ¥107.57 | -14% |
Compare Buda Juice, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Buda Juice, Inc (BUDA) overvalued or undervalued?
What is the fair value of BUDA?
What is the quality score of BUDA?
What is the revenue of Buda Juice, Inc (BUDA)?
What is the net profit margin of BUDA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Buda Juice, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.